Expression of a truncated cystic Fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector in primates

Molecular Therapy

Volumn 15, Issue 4, 2007, Pages 756-763

  Fischer, Anne C ^a   Smith, Carolina I ^a   Cebotaru, Liudmila ^a   Zhang, Xuemei ^a   Askin, Frederic B ^a   Wright, Jerry ^a   Guggino, Sandra E ^a   Adams, Robert J ^a   Flotte, Terence ^b   Guggino, William B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; DNA; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PARVOVIRUS VECTOR; PHOSPHORUS 32; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AEROSOL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; IMMUNOPRECIPITATION; IN VIVO GENE TRANSFER; MACACA; NONHUMAN; PROTEIN EXPRESSION; PSEUDOTYPING; RESPIRATORY EPITHELIUM; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; BASE SEQUENCE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DEPENDOVIRUS; DNA PRIMERS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; MACACA MULATTA; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; TRANSFECTION;

ADENO-ASSOCIATED VIRUS; ANIMALIA; CYTOMEGALOVIRUS; PRIMATES;

EID: 33947255488     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300059     Document Type: Article

References (33)

1. Welsh, MJ (2001). Metabolic and molecular basis of inherited disease In: Scriver CR (eds), 8th edn. McGraw-Hill: New York. pp 5121-5189.
2. Flotte, TR (1999). Gene therapy for cystic fibrosis. Curr Opin Mol Ther 4: 510-516.
3. Welsh, MJ (1999). Gene transfer for cystic fibrosis. J Clin Invest 9: 1165-1166.
4. Monahan, PE and Samulski, RJ (2000). Adeno-associated virus vectors for gene therapy: More pros than cons? Mol Med Today 11: 433-440.
5. Aitken, ML, Moss, RB, Waltz, DA, Dovey, ME, Tonelli, MR and McNamara, SC et al. (2001). A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum Gene Ther 15: 1907-1916.
6. Flotte, TR, Zeitlin, PL, Reynolds, TC, Heald, AE, Pedersen, P and Beck, S et al. (2003). Phase I trial of intranasal and endobronchial administration of a recombinant adenoassociated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical study. Hum Gene Ther 11: 1079-1088.
7. Wagner, JA, Reynolds, T, Moran, ML, Moss, RB, Wine, JJ and Flotte, TR et al. (1998). Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus. Lancet 9117: 1702-1703.
8. Moss, RB, Rodman, D, Spencer, LT, Aitken, ML, Zeitlin, PL and Waltz, D et al. (2004). Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial. Chest 2: 509-521.
9. Duan, D, Yue, Y, Yan, Z, McCray, PB Jr and Engelhardt, JF (1998). Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum Gene Ther 18: 2761-2776.
10. Zabner, J, Seiler, M, Walters, R, Kotin, RM, Fulgeras, W and Davidson, BL et al. (2000). Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J Virol 8: 3852-3858.
11. Duan, D, Yue, Y, Yan, Z, Yang, J and Engelhardt, JF (2000). Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J Clin Invest 11: 1573-1587.
12. Yan, Z, Zak, R, Luxton, GW, Ritchie, TC, Bantel-Schaal, U and Engelhardt, JF et al. (2002). Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J Virol 5: 2043-2053.
13. Bals, R, Xiao, W, Sang, N, Weiner, DJ, Meegalla, RL and Wilson, JM et al. (1999). Transduction of well-differentiated airway epithelium by recombinant adenoassociated virus is limited by vector entry. J Virol 7: 6085-6088.
14. Halbert, CL, Allen, JM and Miller, AD (2001). Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J Virol 14: 6615-6624.
15. Virella-Lowell, I, Zusman, B, Foust, K, Loiler, S, Conlon, T and Song, S et al. (2005). Enhancing rAAV vector expression in the lung. J Gene Med 7: 842-850.
16. Flotte, TR, Schwiebert, EM, Zeitlin, PL, Carter, BJ and Guggino, WB (2005). Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy. Hum Gene Ther 8: 921-928.
17. Zhang, L, Wang, D, Fischer, H, Fan, PD, Widdicombe, JH and Kan, YW et al. (1998). Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes. Proc Natl Acad Sci USA 17: 10158-10163.
18. Monahan, PE and Samulski, RJ (2000). AAV vectors: Is clinical success on the horizon? Gene Ther 1: 24-30.
19. Song, S, Morgan, M, Ellis, T, Poirier, A, Chestnut, K and Wang, J et al. (1998). Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci USA 24: 14384-14388.
20. Sirninger, J, Muller, C, Braag, S, Tang, Q, Yue, H and Detrisac, C et al. (2004). Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector. Hum Gene Ther 9: 832-841.
21. Beck, SE, Laube, BL, Barberena, CI, Fischer, AC, Adams, RJ and Chestnut, K et al. (2002). Deposition and expression of aerosolized rAAV vectors in the lungs of Rhesus macaques. Mol Ther 4: 546-554.
22. Fischer, AC, Beck, SE, Smith, CI, Laube, BL, Askin, FB and Guggino, SE et al. (2003). Successful transgene expression with serial doses of aerosolized rAAV2 vectors in Rhesus macaques. Mol Ther 6: 918-926.
23. Trapnell, BC, Chu, CS, Paakko, PK, Banks, TC, Yoshimura, K and Ferrans, VJ et al. (1991). Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci USA 15: 6565-6569.
24. Cheng, SH, Gregory, RJ, Marshall, J, Paul, S, Souza, DW and White, GA et al. (1990). Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 4: 827-834.
25. Chu, CS, Trapnell, BC, Curristin, SM, Cutting, GR and Crystal, RG (1992). Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. J Clin Invest 3: 785-790.
26. Flotte, TR, Afione, SA, Solow, R, Drumm, ML, Markakis, D and Guggino, WB et al. (1993). Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J Biol Chem 5: 3781-3790.
27. Zhang, LN, Karp, P, Gerard, CJ, Pastor, E, Laux, D and Munson, K et al. (2004). Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway. Mol Ther 6: 990-1002.
28. Ostedgaard, LS et al. (2005). A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia. Proc Natl Acad Sci USA 8: 2952-2957.
29. Afione, SA, Wang, J, Walsh, S, Guggino, WB and Flotte, TR (1999). Delayed expression of adeno-associated virus vector DNA. Intervirology 4: 213-220.
30. Kearns, WG, Afione, SA, Fulmer, SB, Pang, MC, Erikson, D and Egan, M et al. (1996). Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther 9: 748-755.
31. Carroll, TP, Morales, MM, Fulmer, SB, Allen, SS, Flotte, TR and Cutting, CR et al. (1995). Alternate translation initiation codons can create functional forms of cystic fibrosis transmembrane conductance regulator. J Biol Chem 20: 11941-11946.
32. Zolotukhin, S, Potter, M, Zolotukhin, I, Sakai, Y, Loiler, S and Fraiter, TJ et al. (2002). Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 2: 158-167.
33. Zhang, XM, Wang, XT, Yue, H, Leung, SW, Thidbodeau, PH and Thomas, PJ et al. (2003). Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator. J Biol Chem 51: 51232-51242.